Ansa Biotechnologies
ActiveNext-generation DNA synthesis using enzymes
What it does
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
Next to it in Healthcare and bio · enzyme-based DNA synthesis platform
- Nomic BioY Combinator W20
Nomic is doing for proteins what Illumina has done for DNA
- Able HealthY Combinator W16
Able Health gets doctors paid more for higher quality care
- VedaBioY Combinator S21
CRISPR powered Diagnostics with results in minutes.
- KolibriSOSV SOSV IndieBio NY 06
Using sound to enable advanced therapies
- Sigma GeneticsY Combinator W17
Sigma Genetics is a biotechnology company that is building…
- Loop GenomicsY Combinator W16
Novel long-read DNA sequencing technology
- UnimaY Combinator W16
Fast and low-cost diagnostics for real time disease surveillance
- Algen BiotechnologiesY Combinator W20
Using CRISPR to find treatments for cancer and inflammation